ICD-10 Coding/Neoplasms

From Wikiversity
Jump to navigation Jump to search

This lesson introduces ICD-10-CM Neoplasms.

Objectives and Skills[edit | edit source]

Objectives and skills for this lesson include:

  1. Apply ICD-10-CM coding guidelines for accurate selection and sequencing of diagnosis codes commonly used to describe neoplasms
  2. Apply ICD-10-PCS coding guidelines for accurate selection of procedure codes commonly used to diagnose and treat neoplasms

Guidelines[edit | edit source]

Guidelines Introduction Video

Chapter 2 Guidelines Powerpoint.

Start Here[edit | edit source]

ICD-10-CM Official Guidelines for Coding and Reporting FY2019[edit | edit source]

Chapter 2 specific guidelines can be found on pages 29-36 of this document

Part 1: Diagnoses[edit | edit source]

CG I.C.2. Chapter 2: Neoplasms (C00-D49) General guidelines[edit | edit source]

CG I.C.2.a. Treatment directed at the malignancy[edit | edit source]
CG I.C.2.b. Treatment of secondary site[edit | edit source]
CG I.C.2.c. Coding and sequencing of complications[edit | edit source]
CG I.C.2.c.1) Anemia associated with malignancy[edit | edit source]
CG I.C.2.c.2) Anemia associated with chemotherapy, immunotherapy and radiation therapy[edit | edit source]
CG I.C.2.c.3) Management of dehydration due to the malignancy[edit | edit source]
CG I.C.2.c.4) Treatment of a complication resulting from a surgical procedure[edit | edit source]
CG I.C.2.d. Primary malignancy previously excised[edit | edit source]
CG I.C.2.e. Admissions/Encounters involving chemotherapy, immunotherapy and radiation therapy[edit | edit source]
CG I.C.2.e.1) Episode of care involves surgical removal of neoplasm[edit | edit source]
CG I.C.2.e.2) Patient admission/encounter solely for administration of chemotherapy, immunotherapy and radiation therapy[edit | edit source]
CG I.C.2.e.3) Patient admitted for radiation therapy, chemotherapy or immunotherapy and develops complications[edit | edit source]
CG I.C.2.f. Admission/encounter to determine extent of malignancy[edit | edit source]
CG I.C.2.g. Symptoms, signs, and abnormal findings listed in Chapter 18 associated with neoplasms[edit | edit source]
CG I.C.2.h. Admission/encounter for pain control/management[edit | edit source]
CG I.C.2.i. Malignancy in two or more noncontiguous sites[edit | edit source]
CG I.C.2.j. Disseminated malignant neoplasm, unspecified[edit | edit source]
CG I.C.2.k. Malignant neoplasm without specification of site[edit | edit source]
CG I.C.2.l. Sequencing of neoplasm codes[edit | edit source]
CG I.C.2.l.1) Encounter for treatment of primary malignancy[edit | edit source]
CG I.C.2.l.2) Encounter for treatment of secondary malignancy[edit | edit source]
CG I.C.2.l.3) Malignant neoplasm in a pregnant patient[edit | edit source]
CG I.C.2.l.4) Encounter for complication associated with a neoplasm[edit | edit source]
CG I.C.2.l.5) Complication from surgical procedure for treatment of a neoplasm[edit | edit source]
CG I.C.2.l.6) Pathologic fracture due to a neoplasm[edit | edit source]
CG I.C.2.m. Current malignancy versus personal history of malignancy[edit | edit source]
CG I.C.2.n. Leukemia, Multiple Myeloma, and Malignant Plasma Cell Neoplasms in remission versus personal history[edit | edit source]
CG I.C.2.o. Aftercare following surgery for neoplasm[edit | edit source]
CG I.C.2.p. Follow-up care for completed treatment of a malignancy[edit | edit source]
CG I.C.2.q. Prophylactic organ removal for prevention of malignancy[edit | edit source]
CG I.C.2.r. Malignant neoplasm associated with transplanted organ[edit | edit source]

Part 2 : Procedures[edit | edit source]

Excision, Resection, or Destruction of a body part

Excision vs Resection

-      Excision[1] – sentinel lymph removed

-      Resection – the entire lymph node chain removed

Destruction: physical eradication of all or a portion of a body part by direct use of energy, force, or a destructive agent (Ex. Laser: Radiation Therapy)

What is the root operation for “Antineoplastic chemotherapy”? Introduction

Learning Resources[edit | edit source]

Cancer Screening

Cell Cycle : Cancer[2]

Characteristics / Classifications of Neoplasms PPT [3]

How to become a Cancer Registry Professional? Website [4]

Common Surgical Procedures[5]

Activities[edit | edit source]

Cancer Pathophysiology Quiz[6]

Visit the following the National Cancer Institute website[7] and answer the following question: What is cancer?

Check your understanding:

pain
  • What is G89.3? code for neoplasm-related pain
  • Where is the following guideline located ? ICD-10-CM / chapter 6 : Diseases of the Nervous System (G00 - G99)
    • Coding Guideline:[9]
    • Neoplasm Related Pain Code G89.3 is assigned to pain documented as being related, associated or due to cancer, primary or secondary malignancy, or tumor. This code is assigned regardless of whether the pain is acute or chronic. This code may be assigned as the principal or first-listed code when the stated reason for the admission/encounter is documented as pain control/pain management. The underlying neoplasm should be reported as an additional diagnosis. When the reason for the admission/encounter is management of the neoplasm and the pain associated with the neoplasm is also documented, code G89.3 may be assigned as an additional diagnosis. It is not necessary to assign an additional code for the site of the pain. See Section I.C.2 for instructions on the sequencing of neoplasms for all other stated reasons for the admission/encounter (except for pain control/pain management).
Malignant melanoma


What does term “Malignant[10]” mean?

  • Tending to become worse and cause death
  • Describing a cancer
  • Resistant to treatment


Summary and Key Terms[edit | edit source]

Bam Table/Image

BAM Table:

Behavior (6 different choices) Anatomical Site Morphology type
1)   Malignant Primary site where neoplasm originated Lung, breast, etc. ·     describes the size, shape and structure of the cells; leukemia, melanoma, sarcoma, adenocarcinoma, fibroma, glioma, etc.

If morphology is stated, coder must locate the morphology of the tumor in the Index to Diseases and Injuries

·     For example, lipoma, melanoma, sarcoma have specific codes included in the Index

·     However, not every entry in Index will include codes

·     For example, glioma, subependymal, brain has a cross reference to – see Neoplasm, uncertain behavior, by site (brain)

Malignant Primary with Contiguous Sites Overlaps 2 or more contiguous sites should be classified to the subcategory/code “.8” (unless the combination is specifically indexed elsewhere Ex: Lesion of the jejunum and ileum
2)    Malignant Secondary ·     site to which neoplasm has spread (also known as the metastatic site)

·     patient may have a metastatic tumor, but the site of the primary tumor cannot be found

·     “new primary” occurs when patient develops cancer a second time and is unrelated to the first cancer site

·     “recurrence” is when the original cancer recurs in the same organ

·     Cells of the secondary site do not resemble the cells of the organ where it was found

-       Patient stated as having an unknown primary origin

-       Code for secondary site where found

-       Code for primary malignant of unknown site

 
3)    In situ (in place) malignant changes in cells but surrounding tissue has not been invaded
4)    Benign tumor growth does not invade adjacent structures or spread to distant sites
5)    Uncertain pathologist cannot determine whether benign or malignant
     6) Unspecified      Behavior neither the behavior nor the histology is specified in the diagnosis Ex: “Growth,” “Neoplasm,” “Tumor”


See Also[edit | edit source]

https://en.wikipedia.org/wiki/ICD-10_Chapter_II:_Neoplasms[11]

Reporting Pain in ICD-10-CM[12]

Chemotherapy Dosage






References[edit | edit source]

  1. Jennifer Whitlock RN MSN (May 29, 2018). "How and Why Excisions Are Performed During a Surgery". Verywell Health. Retrieved 2019-05-10.
  2. Cancer, retrieved 2019-05-10
  3. Subramani Parasuraman (2013-10-20). Neoplasia Characteristics and classification of cancer. https://www.slideshare.net/ParasuramanParasuraman/neoplasia-1-27391892. 
  4. BECOMING A CANCER REGISTRY PROFESSIONAL - SEER REGISTRARS In-text: (SEER, 2019) Your Bibliography: SEER. (2019). Becoming a Cancer Registry Professional - SEER Registrars. [online] Available at: https://seer.cancer.gov/registrars/howto.html [Accessed 10 May 2019].
  5. "Surgical Procedures". Verywell Health. Retrieved 2019-05-10.
  6. "Cancer Pathophysiology Quiz". Health Information Technology Notifications | HITNOTS. 2015-07-14. Retrieved 2019-05-10.
  7. "What Is Cancer?". National Cancer Institute. 2007-09-17. Retrieved 2019-05-10.
  8. "Remission vs. Relapse". Sarah Cannon. Retrieved 2019-05-10.
  9. "Acrobat Accessibility Report" (PDF). www.cms.gov. Retrieved 2019-05-10.
  10. "NCI Dictionary of Cancer Terms". National Cancer Institute. 2011-02-02. Retrieved 2019-05-10.
  11. "ICD-10 Chapter II: Neoplasms". Wikipedia. 2018-05-10. https://en.wikipedia.org/w/index.php?title=ICD-10_Chapter_II:_Neoplasms&oldid=840572757. 
  12. "Reporting Pain in ICD-10-CM". Coding Strategies. Retrieved 2019-05-10.